Association of uric acid with change in kidney function in healthy normotensive individuals.
about
Uric acid lowering therapies for preventing or delaying the progression of chronic kidney diseaseNew Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseUric acid, hyperuricemia and vascular diseasesHypertension and chronic kidney disease: controversies in pathogenesis and treatmentUric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant.ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approachesAssociation of a polymorphism in a gene encoding a urate transporter with CKD progression.Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar NephrosclerosisSerum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies.Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients.Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney diseaseChronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors"Correlation between renal function and common risk factors for chronic kidney disease in a healthy middle-aged population: a prospective observational 2-year study.Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implicationsRe-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels--a four-years prospective cohort study in TaiwanUric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.Serum uric acid and chronic kidney disease: the role of hypertension.Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study.Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study.Simultaneous determination of plasma creatinine, uric acid, kynurenine and tryptophan by high-performance liquid chromatography: method validation and in application to the assessment of renal function.Effect of uric-acid-lowering therapy on progression of chronic kidney disease: a meta-analysis.Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.Influence of changes in serum uric acid levels on renal function in elderly patients with hypertension: a retrospective cohort study with 3.5-year follow-up.A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-ReviewManagement of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of NephropathyUric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease?Uric acid as a target of therapy in CKD.Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.Allopurinol for prevention of progression of kidney disease with hyperuricemia.Uric acid and chronic kidney disease: A time to act?Novel drugs and intervention strategies for the treatment of chronic kidney disease.Neck circumference predicts renal function decline in overweight women: A community-based prospective cohort study.Predialysis chronic kidney disease in 2010: Novel targets for slowing CKD progression.The challenges of gout management in the elderly.Gout and its comorbidities: implications for therapy.
P2860
Q24235651-3B95BCAF-13F7-4CED-8FC0-7E12B7CFB93BQ26739475-DF4DB0A2-602D-49EF-912D-5F75A80980FCQ26850727-1D60BFD3-0DE6-4DC6-A574-B915BB4A3BF0Q26851271-9C0EB8E9-F0A7-41A5-916C-43C9A5C19C04Q33358818-B43D20CE-0651-403D-8C08-72B5F688893BQ33602553-D925E849-9E20-419D-B175-41972DE5EC1EQ33715840-1A9B4725-F68A-4FAC-9DAB-41F0454DE492Q33752285-D2ABCE85-6177-4C77-993B-C9CA49EE094AQ33800813-0E1E1038-C038-4CAE-B642-488E243E6D1BQ33822935-525DAA5B-4247-4716-8A16-FD85E2E63263Q34317722-1EE14DFF-3D66-487A-9749-6BE40DBE3B3EQ34367656-2FDF1E56-446C-4C1D-9A98-FB0D5B4BB158Q34514455-2E067267-DAAB-4E9B-8834-144ECB209FA1Q34556186-934EA317-1137-4B8F-B9BB-DC8412AEFEFFQ34680658-ABAE9101-4933-4E4A-AB62-60AB20491521Q34682703-22CE9AF4-1C0A-4712-8355-D19384661A0DQ35050256-80B4798D-86A9-4191-BB82-22FC81B91178Q35058882-75BAD91D-1589-48FD-B054-AE76B2D4F207Q35134716-C445C599-12D7-4F5D-A160-82F9C32537EDQ35209656-757AFBE7-992C-4E31-9FB4-3EE6D6E73452Q35227649-B46D1ED7-AC1D-4314-B1BC-BBB96E65EB2EQ35605560-E8C0948D-0F26-4994-9135-6AE91793A005Q35620128-EF36BC0E-6F11-4EE4-AA62-9E19C4D5F8E3Q35913926-5BE62576-86AE-448F-A1E9-5BDC26DFC0ABQ35985659-D065FDBD-E355-427F-9850-437F4A337178Q36255567-8BA456DB-B3AF-4199-884E-B794EBF4C832Q36373688-0AFE737D-3F3E-4BBE-AECE-B16929344D46Q36426457-BCFB800B-EDAA-4D4D-8152-6932E2CAB6C4Q36471751-5631D156-7B8F-47F7-A7D1-CA0FAC82D0ADQ36476464-6C4B398A-7099-454D-B1DB-A360118BD866Q36741005-B2AEE5F7-A157-4A73-B384-40AAF5BCCFB7Q36799689-4C06D34E-90C2-49D3-8343-A63CD4133C78Q36801587-5A8795F3-5A6E-44AF-BA97-F0E68F4EADF0Q37091149-CF406C67-BF31-4542-AB7A-881FCD523D2AQ37195441-799AF21D-CF51-4FAB-A323-091257AA7E9EQ37219043-5E35AFED-E10B-44B4-B1FC-A8354F4FDDB2Q37257080-E2366598-22CE-453F-8DAC-A9C4217B7B70Q37833470-5389FCBD-3AFE-4E6A-B8AC-666047B533FAQ37910891-6B3428E0-35F9-4D9A-A86F-BED18FAC478FQ38040777-B504D231-0FDE-47E0-94E4-1906FA0CCD19
P2860
Association of uric acid with change in kidney function in healthy normotensive individuals.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Association of uric acid with ...... lthy normotensive individuals.
@en
Association of uric acid with ...... lthy normotensive individuals.
@nl
type
label
Association of uric acid with ...... lthy normotensive individuals.
@en
Association of uric acid with ...... lthy normotensive individuals.
@nl
prefLabel
Association of uric acid with ...... lthy normotensive individuals.
@en
Association of uric acid with ...... lthy normotensive individuals.
@nl
P2093
P1476
Association of uric acid with ...... lthy normotensive individuals.
@en
P2093
Antonella Esposito
Claudio Verdura
Gianni Bellomo
Mario Timio
Paolo Saronio
Sandro Venanzi
P304
P356
10.1053/J.AJKD.2010.01.019
P577
2010-04-10T00:00:00Z